Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Tongue Cover Introduces a New Way to Take the Bitterness Out of Medicine
A revolutionary new product that shields the tongue from harsh flavors is on its way courtesy of crowd-funding. - February 05, 2013 - Tongue Cover
CRI-Report Emerging Markets to Promote the Increase in Global Pharmaceutical Markets
By 2016, the average annual growth rate of international pharmaceutical product markets will reach 4.5%, of which that of emerging markets is close to 12%. - February 05, 2013 - China Research and Intelligence
New Research Report on Global Cytomegalovirus (CMV) Infections Market to 2019 by MarketResearchReports
New Market Research Report Added in MarketResearchReports.Biz Database Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 - February 03, 2013 - Market Research Reports.biz
Molecular Medicine Tri-Conference 2013 - Complimentary Hall Passes Now Available
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference (Triconference.com/hallpass) - February 02, 2013 - Cambridge Healthtech Institute
Metrics Inc. Appoints Senior Director of Operations
Joe Cascone will manage the company's manufacturing and other operations. - February 02, 2013 - Metrics, Inc.
New Research Report on Global Neurostimulation Market 2012-2018 by MarketResearchReports
New Market Research Report Added In MarketResearchReports.Biz Database Neurostimulation Market - Advanced Technologies, Global Market and Industry Analysis, Size, Trends and Forecast, 2012 - 2018. - February 02, 2013 - Market Research Reports.biz
New Research Report on Global Statins Market to 2018 by MarketResearchReports
New Market Research Report Added In MarketResearchReports.Biz Database Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share. - February 01, 2013 - Market Research Reports.biz
Pre Book: Global Theranostics Market to 2018 by MarketResearchReports
New Market Research Report Added in MarketResearchReports.Biz Database Theranostics Market - Global Industry Size, Market Share, Trends, Analysis and Forecasts 2012 - 2018. - February 01, 2013 - Market Research Reports.biz
Metrics Inc. Names Vice President of Pharmaceutical Development
Dr. Brad Gold will direct pharmaceutical development and new technologies. - January 30, 2013 - Metrics, Inc.
CHI Releases List of Delegates for Targeting Cancer Stem Cells Symposium in San Francisco, CA
To be held on February 11-12, 2013 at the Moscone North Convention Center, San Francisco, CA - Part of the Molecular Med TRI-CON 2013. - January 26, 2013 - Cambridge Healthtech Institute
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
New Research Report on Global Array Instruments Market to 2012-2016 by MarketResearchReports.biz
New Market Research Report Added in MarketResearchReports.Biz Reports Database Global Array Instruments Market 2012-2016 - January 16, 2013 - Market Research Reports.biz
The Excipact™ Certification Scheme for Pharmaceutical Non-Active Ingredients (Excipients) Webinar
Register now for the SGS global webinar titled "The Excipact™ certification scheme for pharmaceutical non-active ingredients (excipients)" on January 23, 2013." The webinar is complimentary and free of charge. - January 11, 2013 - SGS
Clinical CRO ICRC-Weyer to Enhance Pharmacovigilance Risk Management
The Berlin-based clinical contract research organization (CRO) ICRC-Weyer GmbH is adapting a process of integrating medical review procedures into Pharmacovigilance risk management, a method that will lead to better Pharmacovigilance practices. - January 10, 2013 - ICRC-Weyer GmbH
HealthCarePoint Completes the Integration of Transnational Collaborative Platform for Healthcare and Clinical Research
Connecting HealthCare and Clinical Research - January 08, 2013 - HealthCarePoint
Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector
Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd
2012 - An Award-Winning Year for SFL
This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
Pharma SFE: Translating Strategy Into Action
This two-day conference will focus on how organizations need to focus on translating their strategy into action, discuss real life case studies from top experts in the pharma industry which include the top 50 companies and major players and champions of Pharma industry. They will discuss the importance behind establishing and implementing a successful sales force model to better understand and respond to ever-changing customer needs. - December 16, 2012 - American Leaders
ICRC-Weyer Clinical CRO Looks Back at a Successful Year 2012
ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybody involved in the business. The company looks forward to more constructive partnerships and growth for the year ahead. - December 16, 2012 - ICRC-Weyer GmbH
Bashanda A. Peay, CPHT Recognized by Strathmore's Who's Who Worldwide Publication
Bashanda A. Peay, CPHT of Chesapeake, Virginia has been included in the Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the field of government healthcare. About Bashanda A. Peay, CPHT Ms. Peay has over 6 years experience in the field of... - December 07, 2012 - Strathmore Worldwide
Sentrx Business Development Team Expands
Sentrx continues to add to its Business Development staff by hiring three new outstanding solution oriented individuals. - December 07, 2012 - Sentrx
Wright & McGurk Announces New Campaign to Help Actos® Patients Diagnosed with Bladder Cancer
Wright McGurk is reaching out to consumers who have developed bladder cancer after taking their prescription diabetes medicine, Actos®. Injured patients are encouraged to call Wright McGurk today. - December 06, 2012 - Wright & McGurk
Topix Pharmaceuticals, Inc. Offers a Comprehensive Professional Peel System That Consists of Two Chemical Peels: Intermediate and Advanced with Different Acid
Replenix® MD Perfect 10 Peels (“The peel”) – medical grade, in-office aesthetic treatments designed to provide maximum, predictable and noticeable. These peels contain a synergistic blend of ingredients that visibly reduce the signs of aging with one peel session. - December 04, 2012 - Topix Pharmaceuticals, Inc.
Mevesi Now in Partnership with EPIC Pharmacies
Business Intelligence Provider Collaborates with Major Buying Group. - November 28, 2012 - Mevesi, Inc.
GlaxoSmithKline Honors Institute for Safe Families with $40,000 IMPACT Award
Philadelphia Nonprofit to Receive $40,000 in Funding for Providing Innovative Access to Healthcare - November 15, 2012 - GlaxoSmithKline
New Video Illustrates the Benefits of AdvantaFlex(R) BioPharmaceutical TPE Tubing; Shows Viewers the Tubing’s Versatility
AdvantaPure(R) has released a new video that details the benefits and uses of its biopharmaceutical grade TPE tubing, AdvantaFlex. The flexible, translucent tubing may be sterile welded, heat sealed, and molded into fittings. It is also an excellent choice for peristaltic pumps as it eliminates silicone tubing splices. The video illustrates all of these, points out the tubing’s extensive testing, and notes its suitability for pharmaceutical and biotech applications. - November 15, 2012 - NewAge Industries, Inc.
Dr. Toufigh Gordi to Discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process on November 28, 2012 in Frankfort, Germany. - November 08, 2012 - Rosa & Co LLC
2nd International Conference on Translational Medicine
OMICS Group, the World class Open Access Publisher and Scientific Events Organizer is proud to announce 2nd International Conference on Translational Medicine to be held during August 5-7, 2013 in Chicago-North Shore, USA. Translational Medicine-2013 will bring together representatives from the pharma, government and leading academic research institutions. Together they will share cutting-edge and will discuss on advancement of early stage research to clinical treatments. - November 02, 2012 - OMICS Group Incorporation
International Summit on Clinical Pharmacy & Dispensing
International Summit on Clinical Pharmacy & Dispensing which is going to be held during Nov 18-20, 2013 at San Antonio, Texas, USA. - November 02, 2012 - OMICS Group Incorporation
Wright & McGurk Law Offering Free GranuFlo® Case Evaluation for Injured Dialysis Patients
Wright & McGurk Law is offering a free case evaluation for patients or their loved ones who have been injured by their dialysis treatment. A recent FDA recall could be behind these injuries. - October 25, 2012 - Wright & McGurk
Sentrx Welcomes Addition of New Team Leads
Sentrx introduces four new healthcare professionals to handle growth in adverse event management. - October 25, 2012 - Sentrx
Cen-Med Enterprises Celebrates 20 Years in Business
Cen-Med is celebrating 20 years in the healthcare distribution and services business this year, at their national headquarters located in New Brunswick, NJ. - October 22, 2012 - Cen-Med Enterprises
BDA Advises ICICI Venture on Sale of Radiant Research to Kinderhook's CRA
Business Development Asia LLC ("BDA") is pleased to report that its client Radiant Research, Inc. (“Radiant”) has been acquired by CRA Holdings, Inc (“CRA”), a portfolio company of New York-based private equity firm Kinderhook Industries, LLC... - October 22, 2012 - BDA Partners Ltd
Validated Sterile Single Use Manifold Assemblies Now Available from AdvantaPure(R); Sterilized Parts Save Pharmaceutical Manufacturers Labor & Time
High purity tubing manufacturer AdvantaPure now offers single use molded manifold assemblies that are validated as sterile. This eases the procurement process for pharmaceutical and biopharm companies who use them; customers can now order assemblies that are ready for installation upon receipt. Assemblies made from silicone or AdvantaFlex TPE are gamma irradiated for a sterility assurance level of 10-6. Third-party testing, performed on a regular basis, ensures validation. - October 19, 2012 - NewAge Industries, Inc.
VersaSuite Receives CCHIT Clinical Research Certification
VersaSuite 8.0 is the first ever product to receive CCHIT’s add-on Clinical Research Certification. - October 16, 2012 - VersaSuite
New Jersey Law Firm Assists Victims During Fungal Meningitis Outbreak From Tainted Epidural Steroid Injections
New Jersey personal injury lawyer Scott Grossman is currently investigating the current Fungal Meningitis outbreak in New Jersey and in several other states and is making himself available to victims for consultation. The United States Centers for Disease Control and Prevention (CDC) announced that... - October 15, 2012 - The Grossman Law Firm, LLC
New Omega-3 Structure Function Claim for DHA-Rich Algae Oil
Source-Omega today forwarded new structure function claims for dietary omega-3 intake from a single algae oil. Both omega-3 docosahexaenoic acid (DHA) and omega-3 eicosapentaenoic acid (EPA) are present in their oil. As a supplier, the company has defined DHA-rich algae oil uses in very low density... - October 11, 2012 - Source-Omega
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series
Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. - October 10, 2012 - Rosa & Co LLC
Dr Emil Haldey to Discuss Compounding in the Modern Dermatology Practice at the Mount Sinai Medical Center, October 18, 2012
Dr Emil J. Haldey will speak about history, rationale, and benefits of compounding for modern dermatology practice at the Mount Sinai Medical Center. Dr Haldey continuously researches the field and will discuss the most relevant topics. - October 10, 2012 - Emilior Pharmaceutical Compounding
Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism
Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC
90 People Sickened with Meningitis from Tainted Epidural Pain Shots
The victims of contaminated epidural shots who have contracted meningitis have legal rights. Bagolie Friedman Injury Lawyers is ready to answer any questions the public may have related to these potential claims. As always the consultations are free and confidential. - October 09, 2012 - Bagolie Friedman Injury Lawyers
"Sandoz Will be the Leading Biosimilar Drug Company in 2012, with Revenue of $308 Million" Predicts New Visiongain Report
A new report by Visiongain predicts that Sandoz will retain its position as the global leader in the biosimilar drugs market in 2012. In that year, its three follow-on biologics will achieve $308m in revenue. Combined revenue for the top three companies in that market will grow with a CAGR of close to 25% between 2011 and 2016. Those findings, and others, appear in Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022, published in 1st October 2012. - October 07, 2012 - visiongain
Diabecline Antibiotic Receives Drug Store News Award
Diabecline® first aid antibiotic, offered by pharmaCline®, has been named the winner of the Drug Store News Best New Product award. This recognition was by vote of key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, N.C. Drug Store News... - October 05, 2012 - pharmaCline
IonSense® Introduces the OpenSpot Quick Strips™ for the DART OS Transmission Module™, Providing Rapid Analysis in Food Safety and Product Quality
New Product to be exhibited at the AOAC International Annual Meeting and Exposition in Las Vegas, NV October 1 through October 4, 2012 - October 01, 2012 - IonSense, Inc.
IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry. Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.
New DART-OS Source Demonstrated Live to Meeting Attendees, Highlighting Applications in Food Safety and Forensics. - September 27, 2012 - IonSense, Inc.
Pharma Anti- Counterfeiting 2012 by Virtue Insight Ltd on 18th October 2012, UK
Virtue Insight Ltd is pleased to announce “Pharma Anti- Counterfeiting 2012 – Competences to Combat Counterfeits in EU & USA” on 18th October 2012 at Marriott Marble Arch Hotel, London, UK. Visit: http://www.virtueinsight.com/pharma/Pharma-Anti-Counterfeiting-2012/ This... - September 21, 2012 - Virtue Insight
Source-Omega Claims JAMA Meta-Study Unethical; Calls for Ban of the Word Omega-3 on Drug Labels
Source-Omega says the Food and Drug Administration may need to ban the use of the word omega-3 on all drug labels and descriptions. That is, if omega-3 is only a food word. This is at issue because the company says the September 12th JAMA study also misleads those benefiting from current... - September 20, 2012 - Source-Omega
Ameridose Sponsors Health Connect Partners' 2012 Fall Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its sponsorship of Health Connect Partners’ 2012 Fall Hospital Pharmacy Conference, September 24-26 at the Hyatt Regency in Dallas, Texas. - September 19, 2012 - Ameridose, LLC
The Boulder Group Publishes Net Lease Drug Store Market Research Report
Net lease drug store cap rates compressed across the board - September 15, 2012 - The Boulder Group
pharmaCline Announces Poster Presentation at the Symposium for the Advancement of Wound Care Fall 2012
The poster entitled, “Multi-case Human Field Studies of Diabetic Foot Injuries Treated with Tetracycline delivered by SSPT™: A Novel Delivery System Yields Effective Results” is authored by Dr. Christopher Ayo Otiko, DPM, and features three unique clinical case studies. - September 13, 2012 - pharmaCline